ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 165 filers reported holding ENDOLOGIX INC in Q2 2016. The put-call ratio across all filers is 104.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $10,144,000 | -41.0% | 2,087,238 | -12.0% | 0.66% | -37.5% |
| Q1 2017 | $17,180,000 | +7.2% | 2,372,991 | -15.3% | 1.05% | -2.9% |
| Q4 2016 | $16,024,000 | -42.6% | 2,801,461 | +28.4% | 1.08% | -41.2% |
| Q3 2016 | $27,933,000 | +51.2% | 2,182,278 | +47.2% | 1.84% | +39.7% |
| Q2 2016 | $18,477,000 | +71.0% | 1,482,885 | +14.7% | 1.32% | +64.8% |
| Q1 2016 | $10,805,000 | -4.2% | 1,292,432 | +13.4% | 0.80% | -0.5% |
| Q4 2015 | $11,279,000 | +85.9% | 1,139,313 | +130.3% | 0.80% | +63.9% |
| Q3 2015 | $6,066,000 | +62.9% | 494,743 | +102.1% | 0.49% | -51.6% |
| Q2 2014 | $3,723,000 | +92.7% | 244,795 | +63.0% | 1.01% | +21.8% |
| Q1 2014 | $1,932,000 | -1.8% | 150,146 | +33.1% | 0.83% | -41.2% |
| Q4 2013 | $1,968,000 | – | 112,839 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,121,447 | $5,450,000 | 2.37% |
| Essex Woodlands Management, Inc. | 1,257,468 | $11,699,000 | 2.12% |
| Redmile Group, LLC | 6,368,299 | $30,950,000 | 1.88% |
| Camber Capital Management LP | 7,500,000 | $36,450,000 | 1.78% |
| Sio Capital Management, LLC | 493,060 | $2,396,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 1,575,000 | $7,655,000 | 1.10% |
| PFM Health Sciences, LP | 5,599,466 | $27,213,000 | 0.73% |
| Elk Creek Partners, LLC | 2,087,238 | $10,144,000 | 0.66% |
| Partner Investment Management, L.P. | 99,736 | $485,000 | 0.65% |
| Brown Capital Management | 8,783,162 | $42,686,000 | 0.52% |